Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- priority_score
- Composite prioritisation = 0.30*biology + 0.30*reagent-gap + 0.20*druggability + 0.10*disease + 0.10*novelty. Sub-scores are assigned during LLM-assisted curation — a heuristic ranking, NOT an experimental measurement.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- 1 if in the EV-Map circulating-EV proteome (Rai 2025); 3,422 targets.
- has_known_aptamer
- 1 if aptamer evidence found in PubMed/Aptagen (1,472 targets).
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for this protein AND (aptamer OR SELEX).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
1,942 rows where has_cryoEM = 0, has_known_aptamer = 0 and in_cev_map = 1 sorted by priority_score descending
This data as json, CSV (advanced)
| id | gene_symbol | protein_name | tier | priority_score ▲ | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | drug_count_approved | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Q9NX14 | NDUFB11 | NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial | Tier 1.5 | 0.86 | 0 | 77.56 | 0 | 0 | 0 | 0 | 1 | Microphthalmia with linear skin defects syndrome | 0.7364493324598024 | ||||
| P01911 | HLA-DRB1 | HLA class II histocompatibility antigen, DRB1 beta chain | Tier 1 | 0.84 | 100 | 88.44 | 0 | 0 | 0 | 0 | 1 | rheumatoid arthritis | 0.40051584219092445 | ||||
| Q9UBT7 | CTNNAL1 | Alpha-catulin | Tier 1.5 | 0.795 | 0 | 84.06 | 0 | 0 | 0 | 0 | 1 | Abnormality of the skeletal system | 0.31316995706583495 | ||||
| P35555 | FBN1 | Fibrillin-1 | Tier 1 | 0.78 | 11 | 0 | 0 | 0 | 0 | 1 | Marfan syndrome | 0.8969300970597663 | |||||
| P02671 | FGA | Fibrinogen alpha chain | Tier 1 | 0.77 | 40 | 60.34 | 0 | 0 | 0 | 0 | 1 | familial dysfibrinogenemia | 0.7947496460990987 | ||||
| P03951 | F11 | Coagulation factor XI | Tier 1 | 0.77 | 100 | 86.88 | 0 | 0 | 0 | 0 | 1 | factor XI deficiency | 0.841884208404384 | ||||
| P27037 | ACVR2A | Activin receptor type-2A | Tier 1.5 | 0.769 | 5 | 83.56 | 0 | 0 | 0 | 0 | 1 | hepatocellular carcinoma | 0.4908023126074436 | ||||
| O14958 | CASQ2 | Calsequestrin-2 | Tier 1.5 | 0.767 | 4 | 90.5 | 0 | 0 | 0 | 0 | 1 | catecholaminergic polymorphic ventricular tachycardia | 0.7718998507471558 | ||||
| Q9H3K6 | BOLA2 | BolA-like protein 2 | Tier 1.5 | 0.765 | 0 | 92.69 | 0 | 0 | 0 | 0 | 1 | hepatocellular carcinoma | 0.08093942543094014 | ||||
| Q92956 | TNFRSF14 | Tumor necrosis factor receptor superfamily member 14 | Tier 1.5 | 0.745 | 8 | 79.94 | 0 | 0 | 0 | 0 | 1 | diffuse large B-cell lymphoma | 0.5983171413833771 | ||||
| P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | Tier 1.5 | 0.735 | 0 | 77.38 | 0 | 0 | 0 | 0 | 1 | genetic developmental and epileptic encephalopathy | 0.7513374591580034 | ||||
| P98196 | ATP11A | Phospholipid-transporting ATPase IH | Tier 1.5 | 0.735 | 0 | 82.94 | 0 | 0 | 0 | 0 | 1 | hearing loss, autosomal dominant 84 | 0.5506821963658654 | ||||
| Q9BY67 | CADM1 | Cell adhesion molecule 1 | Tier 1 | 0.734 | 2 | 80.56 | 0 | 0 | 0 | 0 | 1 | Abnormality of the skeletal system | 0.442731358018962 | ||||
| P20702 | ITGAX | Integrin alpha-X | Tier 1.5 | 0.732 | 9 | 88.0 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.41708750879240836 | ||||
| P09603 | Tier 1.5 | 0.729 | 8 | 57.41 | 0 | 0 | 0 | 0 | 1 | type 2 diabetes mellitus | 0.39219340856589974 | ||||||
| P22732 | SLC2A5 | Solute carrier family 2, facilitated glucose transporter member 5 | Tier 1.5 | 0.728 | 0 | 90.56 | 0 | 0 | 0 | 0 | 1 | Prolonged QT interval | 0.3326218692162316 | ||||
| Q9P2B2 | PTGFRN | Prostaglandin F2 receptor negative regulator | Tier 1.5 | 0.728 | 0 | 84.12 | 0 | 0 | 0 | 0 | 1 | type 2 diabetes mellitus | 0.48052208463481294 | ||||
| Q92636 | NSMAF | Protein FAN | Tier 1.5 | 0.725 | 0 | 88.31 | 0 | 0 | 0 | 0 | 1 | placental retention | 0.36802220150078147 | ||||
| Q99497 | PARK7 | Parkinson disease protein 7 | Tier 1 | 0.723 | 88 | 98.44 | 0 | 0 | 0 | 0 | 1 | Young adult-onset Parkinsonism | 0.7264878745993893 | ||||
| O95562 | SFT2D2 | Vesicle transport protein SFT2B | Tier 1.5 | 0.71 | 0 | 78.5 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.38598268164814226 | ||||
| P79483 | HLA-DRB3 | HLA class II histocompatibility antigen, DR beta 3 chain | Tier 1.5 | 0.71 | 2 | 88.38 | 0 | 0 | 0 | 0 | 1 | ||||||
| P01889 | HLA-B | HLA class I histocompatibility antigen, B alpha chain | Tier 1 | 0.708 | 100 | 88.06 | 0 | 0 | 0 | 0 | 1 | COVID-19 | 0.48417012135481613 | ||||
| P03905 | MT-ND4 | NADH-ubiquinone oxidoreductase chain 4 | Tier 1.5 | 0.705 | 0 | 93.94 | 0 | 0 | 0 | 0 | 1 | Leber hereditary optic neuropathy | 0.7517935125709835 | ||||
| P08473 | MME | Neprilysin | Tier 1 | 0.699 | 16 | 96.19 | 0 | 0 | 0 | 0 | 1 | Charcot-Marie-Tooth disease axonal type 2T | 0.7912653398252156 | ||||
| P01615 | IGKV2D-28 | Immunoglobulin kappa variable 2D-28 | Tier 1.5 | 0.695 | 0 | 91.0 | 0 | 0 | 0 | 0 | 1 | cutaneous Leishmaniasis | 0.5868213846274001 | ||||
| Q30154 | HLA-DRB5 | HLA class II histocompatibility antigen, DR beta 5 chain | Tier 1.5 | 0.694 | 4 | 86.75 | 0 | 0 | 0 | 0 | 1 | seasonal allergic rhinitis | 0.19424611770933498 | ||||
| Q9Y678 | COPG1 | Coatomer subunit gamma-1 | Tier 1.5 | 0.692 | 1 | 87.88 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.4905625531390244 | ||||
| P36980 | CFHR2 | Complement factor H-related protein 2 | Tier 1.5 | 0.691 | 4 | 90.62 | 0 | 0 | 0 | 0 | 1 | age-related macular degeneration | 0.5100732932209376 | ||||
| Q92187 | ST8SIA4 | CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase | Tier 1 | 0.69 | 3 | 86.44 | 0 | 0 | 0 | 0 | 1 | systemic lupus erythematosus | 0.43832763677821385 | ||||
| Q8IUH8 | SPPL2C | Signal peptide peptidase-like 2C | Tier 1.5 | 0.69 | 0 | 67.06 | 0 | 0 | 0 | 0 | 1 | osteoarthritis, hip | 0.35379836590273994 | ||||
| Q14520 | HABP2 | Factor VII-activating protease | Tier 1.5 | 0.686 | 0 | 77.62 | 0 | 0 | 0 | 0 | 1 | follicular thyroid carcinoma | 0.46213907606907034 | ||||
| O95399 | UTS2 | Urotensin-2 | Tier 1 | 0.685 | 2 | 58.44 | 0 | 0 | 0 | 0 | 1 | hair color | 0.35316475479030335 | ||||
| Q96MP8 | KCTD7 | BTB/POZ domain-containing protein KCTD7 | Tier 1.5 | 0.685 | 0 | 81.12 | 0 | 0 | 0 | 0 | 1 | progressive myoclonic epilepsy type 3 | 0.8021556079083692 | ||||
| Q99584 | S100A13 | Protein S100-A13 | Tier 1 | 0.681 | 12 | 80.81 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.41302685279153983 | ||||
| Q9HBI1 | PARVB | Beta-parvin | Tier 1 | 0.68 | 3 | 81.75 | 0 | 0 | 0 | 0 | 1 | thyroiditis | 0.28021156500366357 | ||||
| O94842 | TOX4 | TOX high mobility group box family member 4 | Tier 1.5 | 0.68 | 1 | 54.72 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.43085410155338943 | ||||
| Q96DA2 | RAB39B | Ras-related protein Rab-39B | Tier 1.5 | 0.678 | 1 | 88.38 | 0 | 0 | 0 | 0 | 1 | early-onset parkinsonism-intellectual disability syndrome | 0.7782306319395635 | ||||
| O00602 | FCN1 | Ficolin-1 | Tier 1 | 0.675 | 7 | 84.94 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.351581018821974 | ||||
| Q9UI42 | CPA4 | Carboxypeptidase A4 | Tier 1.5 | 0.674 | 5 | 93.69 | 0 | 0 | 0 | 0 | 1 | rheumatoid arthritis | 0.19026118958920038 | ||||
| P08572 | COL4A2 | Collagen alpha-2(IV) chain | Tier 1.5 | 0.673 | 4 | 47.25 | 0 | 0 | 0 | 0 | 1 | porencephaly 2 | 0.7294975109351518 | ||||
| P78357 | CNTNAP1 | Contactin-associated protein 1 | Tier 1.5 | 0.673 | 0 | 81.12 | 0 | 0 | 0 | 0 | 1 | Hypomyelination neuropathy - arthrogryposis | 0.8286745612673082 | ||||
| Q9UK55 | SERPINA10 | Protein Z-dependent protease inhibitor | Tier 1 | 0.672 | 4 | 86.75 | 0 | 0 | 0 | 0 | 1 | macular degeneration | 0.3247169581531489 | ||||
| P02749 | APOH | Beta-2-glycoprotein 1 | Tier 1 | 0.67 | 14 | 93.12 | 0 | 0 | 0 | 0 | 1 | atrial fibrillation | 0.5456247991985232 | ||||
| P06703 | S100A6 | Protein S100-A6 | Tier 1 | 0.67 | 6 | 87.19 | 0 | 0 | 0 | 0 | 1 | neoplasm | 0.10449825238323361 | ||||
| P78552 | IL13RA1 | Interleukin-13 receptor subunit alpha-1 | Tier 1 | 0.67 | 4 | 81.56 | 0 | 0 | 0 | 0 | 1 | type 2 diabetes mellitus | 0.48627783096767857 | ||||
| Q14C86 | GAPVD1 | GTPase-activating protein and VPS9 domain-containing protein 1 | Tier 1.5 | 0.67 | 0 | 62.19 | 0 | 0 | 0 | 0 | 1 | Abnormality of the skeletal system | 0.46694942126454214 | ||||
| Q92997 | DVL3 | Segment polarity protein dishevelled homolog DVL-3 | Tier 1.5 | 0.67 | 9 | 58.91 | 0 | 0 | 0 | 0 | 1 | autosomal dominant Robinow syndrome | 0.7284158836126389 | ||||
| Q9BXX0 | EMILIN2 | EMILIN-2 | Tier 1.5 | 0.67 | 0 | 65.12 | 0 | 0 | 0 | 0 | 1 | type 2 diabetes mellitus | 0.3471636502626859 | ||||
| Q9NVH1 | DNAJC11 | DnaJ homolog subfamily C member 11 | Tier 1.5 | 0.67 | 0 | 84.75 | 0 | 0 | 0 | 0 | 1 | smoking initiation | 0.2238015008808092 | ||||
| Q4L180 | FILIP1L | Filamin A-interacting protein 1-like | Tier 1.5 | 0.67 | 0 | 67.56 | 0 | 0 | 0 | 0 | 1 | Umbilical hernia | 0.375022308318664 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS SELECT f.id, n.gene_symbol, n.protein_name, tg.tier, f.priority_score, f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM, f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive, f.drug_count_approved, f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids, f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score FROM v_target_full f LEFT JOIN target_names n ON n.target_id=f.id LEFT JOIN targets tg ON tg.id=f.id LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id;